Bioethics International’s President, Jennifer E. Miller, PhD, will speak at CBI’s 5th Annual Clinical Data Disclosure and Transparency conference. The conference will focus on regulatory changes at both the U.S. and international level, developing strategies to anonymize and release patient level data, ensuring compliance with disclosure and transparency requirements and achieving meaningful patient engagement through comprehensive lay summaries. Gain insight from an expert speaking faculty, discussing and disseminating the latest information related to Title VIII of FDAAA Final Rule and complimentary NIH policy, EMA Policy 0070, ICMJE requirements, data anonymization, the Good Pharma Scorecard, sharing patient-level data and international registries.
